Biodesix (BDSX) Balance Sheet: Assets & Liabilities

Biodesix (BDSX) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Biodesix reported total assets of $87.48M and total liabilities of $89.94M. Shareholders' equity was negative at −$2.46M, meaning liabilities exceed assets. Total debt stood at $72.85M against $18.99M in cash and short-term investments, a net debt position of $53.87M.

Biodesix Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Biodesix, Inc. (BDSX) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	18.99	26.25	26.28	43.09	32.71	62.13	5.29	5.91
Cash & Short-Term Investments	18.99	26.25	26.28	43.09	32.71	62.13	5.29	5.91
Accounts Receivable	9.04	8.60	7.68	5.07	3.66	15.30	5.29	1.89
Inventory	0.00	1.00	1.40	1.40	2.90	3.20	0.80	0.70
Other Current Assets	4.50	4.64	5.72	5.18	7.25	5.51	1.32	1.41
Total Current Assets	32.52	39.48	39.68	53.33	43.61	86.14	12.70	9.91
Non-Current Assets
Property, Plant & Equipment (Net)	27.81	29.60	29.61	8.82	4.18	3.18	2.12	1.39
Goodwill	15.03	15.03	15.03	15.03	15.03	15.03	11.63	10.80
Intangible Assets	3.88	5.87	7.91	9.80	11.62	13.26	15.09	16.85
Other Non-Current Assets	8.23	7.26	6.86	5.92	1.66	3.46	0.09	0.10
Total Non-Current Assets	54.96	57.76	59.41	39.57	32.48	34.93	28.93	29.14
Total Assets	87.48	97.24	99.10	92.91	76.10	121.07	41.63	39.06
Current Liabilities
Accounts Payable	3.08	2.19	2.93	1.69	1.66	8.96	1.72	0.89
Short-Term Debt	1.37	0.02	0.05	0.05	0.02	11.84	12.16	0.00
Current Portion of Long-Term Debt	0.01	0.02	0.05	0.05	0.02	11.84	-	-
Accrued Liabilities	3.20	10.06	7.71	8.22	3.64	7.79	-	-
Deferred Revenue	0.96	0.68	0.32	0.96	1.85	3.53	1.28	0.49
Other Current Liabilities	12.03	0.64	22.15	10.38	17.76	7.79	7.44	3.09
Total Current Liabilities	17.44	14.32	33.42	22.84	28.96	32.13	22.60	4.47
Non-Current Liabilities
Long-Term Debt	71.48	36.41	35.23	25.00	9.99	15.93	23.81	23.10
Deferred Tax Liabilities	0.00	0.00	0.00	-0.40	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	1.02	0.82	0.71	19.20	17.42	30.45	223.76	209.52
Total Non-Current Liabilities	72.51	62.05	61.10	49.46	27.41	47.78	247.57	232.62
Total Liabilities	89.94	76.37	94.52	72.30	56.37	79.90	270.17	237.09
Stockholders' Equity
Common Stock	0.01	0.15	0.10	0.08	0.03	0.03	0.00	0.00
Retained Earnings	-497.76	-462.50	-419.57	-367.42	-301.97	-258.81	-230.86	-200.14
Accumulated Other Comprehensive Income	0.00	0.00	0.00	0.00	0.00	-121.07	-193.96	-5.57
Additional Paid-in Capital	495.29	483.23	424.05	387.95	321.67	299.95	2.32	7.68
Shares Outstanding	8.25	7.27	4.81	3.88	1.54	-	-	-
Total Stockholders' Equity	-2.47	20.88	4.58	20.61	19.73	41.17	-228.54	-198.03
Total Liabilities & Equity	87.48	97.24	99.10	92.91	76.10	121.07	41.63	39.06

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Biodesix Balance Sheet

How much debt does Biodesix have?

Biodesix had total debt of $72.85M as of Dec 31, 2025, against $18.99M in cash and short-term investments. Total debt was $36.43M a year earlier.

What are Biodesix's total assets?

Biodesix reported total assets of $87.48M as of Dec 31, 2025, down 10.0% from $97.24M a year earlier. Total liabilities were $89.94M.

What is Biodesix's shareholders' equity?

Biodesix's shareholders' equity was negative at −$2.46M as of Dec 31, 2025, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition